Prognosis
Saudi Arabia Plans Human Trial of China’s CanSino Virus Vaccine
- Trial will include 5,000 people in Riyadh, Mecca and Dammam
- Infections in kingdom rising again after Islamic holiday
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Saudi Arabia plans to conduct a clinical trial of a coronavirus vaccine developed by China’s CanSino Biologics on at least 5,000 volunteers.